Smoking and cardiovascular system: Cellular features of the damage

Current Pharmaceutical Design

Volumn 14, Issue 18, 2008, Pages 1771-1777

  Leone, A ^a,c   Landini Jr , L ^b   Biadi, O ^b   Balbarini, A ^b  

^a Royal Society of Health   (United Kingdom)

^b UNIVERSITY OF PISA   (Italy)

^c NONE   (Italy)

Author keywords

Cardiovascular cell damage; Morphologic changes; Smoking

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN; NICOTINE;

ARTERY CALCIFICATION; ARTERY OCCLUSION; ARTERY WALL; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW; CARDIOMYOPATHY; CELL DAMAGE; CELL DEATH; CELL HYPOXIA; CELL INFILTRATION; CIGARETTE SMOKING; CORONARY ARTERY; ELECTRON BEAM TOMOGRAPHY; FIBROSING ALVEOLITIS; HEART INFARCTION; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART MUSCLE NECROSIS; HUMAN; HYALINE DEGENERATION; INFLAMMATION; INTRACELLULAR MEMBRANE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RESPIRATORY FUNCTION; REVIEW; RIBOSOME; SMOKE CARDIOMYOPATHY; THROMBOCYTE AGGREGATION; TOBACCO; VASCULAR NECROSIS;

ANIMALS; ANOXIA; CARDIOVASCULAR DISEASES; CELL DEATH; HUMANS; NECROSIS; SMOKING;

EID: 47349091631     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208784746699     Document Type: Review

References (85)

1. Leone A. Cardiovascular damage from smoking: a fact or belief? Int J Cardiol 1993; 38: 113-7.
2. Sherman CB. Health effects of cigarette smoking. Clin Chest Med 1991; 12(4):643-58.
3. Leone A. The heart: a target organ for cigarette smoking. J Smoking-Related Dis 1992; 3: 197-201.
4. US Department of Health, Education, and Welfare: The health consequences of smoking: a report of the Surgeon General. Cardiovascular disease. Rockville, MD: US Department of Health and Human Services, Public Health Service Office of Smoking and Health. DHHS Publication NO (PHS) 84-50204, 1983.
5. Leone A. Cigarette smoking and health of the heart. J Roy Soc Health 1995; 115:354-5.
6. Hammond EC, Garfinkel L. Coronary heart disease, stroke and aortic aneurysm. Arch Environ Health 1969; 19: 167-82.
7. McBride PE. The health consequences of smoking. Cardiovascular diseases. Med Clin North Am 1992; 76: 333-53.
8. Aronow WS. Effect of passive smoking on angina pectoris. N Engl J Med 1978; 299: 21-4.
9. Sparrow D, Dawber TR, Colton T. The influence of cigarette smoking on prognosis after a first myocardial infarction. J Chronic Dis 1978; 31:425-32.
10. Leone A, Bertanelli F, Mori L, Fabiano P, Bertoncini G. Ventricular arrhythmias by passive smoking in patients with pre-existing myocardial infarction. J Am Coll Cardiol 1992; 3:256 (A).
11. Wilhelmsson C, Vedin JA, Elmfeldt D, Tibblin G, Wilhelmsen L. Smoking and myocardial infarction. Lancet 1975; 1: 415-20.
12. Auerbach O, Carter HW, Garfinkel L, Hammond EC. Cigarette smoking and coronary heart disease, a macroscopic and microscopic study. Chest 1976; 70: 697-705.
13. Reid DD, Hamilton PJS, McCartney P, Rose G. Smoking and other risk factors in coronary heart disease in British civil servants. Lancet 1976; 11: 979-84.
14. Glantz SA, Parmley WW. Passive smoking and heart disease. JAMA 1995; 273: 1047-53.
15. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol 1094; 24: 546-54.
16. Meinert CL, Forman S, Jacobs DR, Staniler J. Cigarette smoking as a risk factor in men with a prior history of myocardial infarction. J Chronic Dis 1979; 32: 415-25.
17. Glantz SA, Parmley WW. Passive smoking and heart disease: epidemiology, physiology, and biochemistry. Circulation 1991; 83: 1-12.
18. Baer L, Radichevich I. Cigarette smoking in hypertensive patients. Blood pressure and endocrine responses. Am J Med 1985; 78: 564-8.
19. Celermajer DS, Adams MR, Clarkson P, Robinson J, McRedie R, Donald A, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-4.
20. Leone A, Lopez M. Oral contraception, ovarian disorders and tabacco i myocardial infarction of woman. Pathologica, 1986; 78: 237-42.
21. Pojola S, Siltanen P, Romo M. Five-year survival of 728 patients after myocardial infraction. Br Heart J 1980; 43: 176-83.
22. Leone A. Relationship between cigarette smoking and other coronary risk factors in atherosclerosis: risk of cardiovascular disease and preventive measures. Curr Pharm Design 2003; 2417-23.
23. Wald N, Howard S, Smith PG. Association between atherosclerotic diseases and carboxyhemoglobin levels in tobacco smokers. Br Med J 1973; 1: 761-5.
24. Watts DT. The effects of nicotine and smoking on the secretion of epinephrine. Ann NY Acad Sci 1966; 90: 74-80.
25. Astrup P, Kjeldsen K. Model studies linking carbon monoxide and/or nicotine to arteriosclerosis and cardiovascular disease. Prev Med 1979; 8: 295-302.
26. Kjeldsen K, Thomsen HK, Astrup P. Effects of carbon monoxide on myocardium: Ultrastructural changes in rabbits after moderate, chronic exposure. Circ Res 1974; 34: 339-48.
27. Zevin S, Saunders S, Gourlay SG, Jacob P, Benowitz NL. Cardiovascular effects of carbon monoxide and cigarette smoking. J Am Coll Cardiol 2001; 38: 1633-8.
28. Dwyer EMJ, Turino GM. Carbon monoxide and cardiovascular disease. N Engl J Med 1989; 321: 1474-5.
29. Majno G, LaGattuta M, Thompson TE. Cellular death and necrosis: Chemical, physical, and morphologic changes in rat liver. Vircows Arch 1960; 333: 421-65.
30. Bajusz E. The terminal electrolyte-shft mechanism in heart muscle; its significance in the pathogenesis and prevention of necrotizing cardiomyopathies. In: Bajusz E Ed., Electrolytes and cardiovascular diseases, Karga, Basel 1965; Vol 1.
31. Bajusz: E, Jasmin G. Observations on histochemical differential-diagnosis between primary and secondary cardiomyopathies. Am Heart J 1965; 69; 83-92.
32. Leone A, Bertanelli F, Mori L, Fabiano P, Battaglia A. Features of ischaemic cardiac pathology resulting from cigarette smoking. J Smoking-Related Dis 1994; 5: 109-14.
33. Trump BJ, Berezesky I. The reactions of cells to lethal injury: oncosis and necrosis- the role of calcium. In: Lockshin RA et al. Eds: When cells die-A comprehensive evaluation of apoptosis and programmed cell death. Wiley-Liss, New York 1998; 57-96.
34. Leone A. Biochemical markers of cardiovascular damage from tobacco smoke. Curr Pharm Design 2005; 11: 2199-2208.
35. Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med 1998; 3: 21-8.
36. Ball K, Turner R. Smoking and the heart: the basis for action. Lancet 1974; 2: 822-6.
37. Benowitz NL, Jacob P III, Jones RT, Rosemberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exper Ther 1982; 221: 368-72.
38. Leone A, Mori L, Bertanelli F, Fabiano P, Filippelli M. Indoor passive smoking: its effect on cardiac performance. Int J Cardiol 1991; 8: 247-52.
39. Adams JD, Erickson HH, Stone HL. Myocardial metabolism during exposure carbon monoxide in the conscious dog. J Appl Physiol 1973; 34: 238-42
40. Horwath SK Raven PB, Dahms TE, Gray DJ. Maximal aerobic capacity at different levels of carboxyhemoglobin. J Appl Physiol 1975; 38: 300-3.
41. Lewey FH, Drabkin DD. Experimental chronic carbon monoxide poisoning of dogs. Am J Med Sci 1944; 208: 502-11.
42. Ehrich WE, Bellet S, Lewey FH. Cardiac changes from CO poisoning. Am J Med Sci 1944; 208: 512-23.
43. Musselman NP, Groff WA, Yevich PP, Wilinsky FT, Weeks MH, Oberst FW. Continuous exposure of laboratory animals to low concentration of carbon monoxide. Aerosp Med 1959; 30: 524-9.
44. Astrup P. Some physiological and pathological effects of moderate carbon monoxide exposure. Br Med J 1972; 4: 447-52.
45. Anderson RF, Allensworth DC, DeGroot WJ. Myocardial toxicity from carbon monoxide poisoning. Ann Int Med 1967; 11: 72-82.
46. Thomsen RK, Kjeldsen K. Threshold limit for carbon monoxide-induced myocardial damage. Arch Environ Health 1974; 29: 73-8.
47. Zhu BQ, Sun YP, Sievers RE, Isenberg WK Glantz SA, Parmley WW. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 1993; 21: 225-32.
48. Gvozdjakova A, Bada V, Sany L, Kucharska J, Kruty F, Bozek P, et al. Smoke cardiomyopathy: disturbance of oxidative processes in myocardial mitachondria. Cardiovasc Res 1984; 18: 229-32.
49. Bing RJ, Castellanos A, Gradel E, Lupton C, Siegel A. Experimental myocardial infarction: circulatory, biochemical and pathologic changes. Am J Med Sci 1956; 232: 533-54.
50. Caulfield J, Klionsky B. Myocardial ischemia and early infarction; an electron microscopic study. Am J Pathol 1959; 35: 489-523.
51. Bryant RE, Thomas WA, O'Neal RM. An electron microscopic study of myocardial ischemia in the rat. Circ Res 1958; 6: 699-709.
52. Cantin K Leone A. Morphology of myocardial infarction. Meth Achiev Exp Pathol 1981; 10: 244-84.
53. Schlessinger MJ, Reiner L. Focal myocytolysis of the heart. Am J Pathol 1955; 31: 443-59.
54. Sommers HM, Jennings RB. Experimental acute myocardial infarction. Histologic and histochemical studies of early myocardial infarct induced by temporary or permanent occlusion of a coronary artery. Lab Invest 1964; 13: 1491-503.
55. Hill P, Wynder L. Smoking and cardiovascular disease. Am Heart J 1974; 87:491-6.
56. Lough J. Cardiomyopathy produced by cigarette smoke. Ultrastructural observations in guinea pigs. Arch Pathol Lab Med 1978; 102: 377-80.
57. Astrup P, Kjeldsen K, Wanstrup J. The effects of exposure to carbon monoxide, hypoxia and hyperoxia on the development of experimental atherosclerosis in rabbits. In: Jones RJ ed, Proceedings of the Second International Symposium on Atherosclerosis. Springer Verlag, New York, NY, USA, 1970; 108-11.
58. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 1388-98.
59. Felker GM, Thompson R, Hare J, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-84.
60. Roggendorf W, Neumann H, Thorn HL, Schneider H, Sarasa-Corral JL. Histologic examination of the rat after long-term exposure to subtoxic automotive exhaust gas. Arch Toxicol 1981; 47: 247-56.
61. Leone A, Lopez M. Myocardial infarction and coronary damage in the smokers: histopathologic features. XII Inter-American Congress of Cardiology, Vancouver, Canada, 1985; 13 A.
62. Winniford MD, Jansen DE, Reynolds JA, Apprill P, Black WH, Hillis LD. Cigarette smoking-induced: coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin. Am J Cardiol 1987; 59: 203-7.
63. Talks SJ, Chong NH, Gibson JM, Dodson PM. Fibrinogen, cholesterol and smoking as risk fctors for non-arteritic anterior ischaemic optic neuropathy. Eye 1995; 9: 85-8.
64. Prentice RC, Carrol R, Scanlon PJ, Thomas JXJ. Recent exposure to cigarette smoke increases myocardial infaret size. J Am Coll Cardiol 1989; 13: 124A.
65. Quillen JE, Rossen JD, Oskarsson HJ, Minor RLJ, Lopez AG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993; 22: 642-7.
66. Tsiara S, Elisaf M, Mikhailidis DP. Influence of smoking on predictors of vascular disease. Angiology 2003; 54: 507-30.
67. Cooper J, Douglas AS. Fibrinogen level as a predictor of mortality in survivors of myocardial infarction. Fibrinolysis 1991; 5: 105-8.
68. Resch KL, Ernst E, Matai A, Paulsen HF. Fibrinogen and viscosity as risk factors for subsequent cardiovascuar events in stroke survivors. Ann Intern Med 1992; 117: 371-5.
69. Zhu B, Parmley WW. Hemodinamic and vascular effects of active and passive smoking. Am Heart J 1995; 130: 1270-75.
70. Klein LW, Pichard AD, Holt J, Smith H, Gorlin R, Teichbolz LE. Effects of chronic tobacco smoking on coronary circulation. J Am Coll Cardiol 1983; 1: 421-6.
71. Schmermund A, Baunigart D, Gorge G, Seibel R, Gronemeyer D, Ge J, et al. Coronary artery calcium in acute coronary syndromes. Circulation 1997; 96: 1461-9.
72. Ehrich WE, Bellet S, Lewey FH. Cardiac changes from carbon monoxide poisoning. Am J Med Sci 1944; 208: 511-21.
73. Aronow WS. Effect of carbon monoxide on cardiovascular disease. Prev Med 1979; 8: 271-8.
74. Chance B, Erechinska M, Wagner M. Mitochondrial response to CO toxicity. Ann NY Acad Sci 1970; 174; 193-204.
75. Hayes JM, Hall GV. The myocardial toxicity of carbon monoxide. Med J Aust 1964; 1: 865-8.
76. Satran D, Henry CR, Adkinson C, Nicholson RN, Bracha Y, Henry TD. Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J Am Coll Cardiol 2005; 45: 1513-6.
77. Marius-Nunez AL. Myocardial inflarction with normal coronary arteries after acute exposure to carbon monoxide. Chest 1990; 97: 491-4.
78. Fuster V, Cheseboro JH, Frye RL, Elveback LR. Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation 1981; 63: 546-51.
79. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64: 111-26.
80. Ferrari R, Ceconi C, Curello S, Carponi A, Alfieri O, Pardini A, et al. Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med 1991; 91: 95S-105S.
81. Chang DD, Clayton DA. A mammalian mitochondria. RNA processing activity contains nucleus-encoded RNA. Science 1987; 235: 1178-84.
82. van den Bosch BJC, van den Burg CMM, Scoonderwoerd K, Lindsey PJ, Scholte HR, deCoo RFK et al. Regional absence of mitochondria causing energy depletion in the myocardium of muscle LIM protein knockout mice. Cardiovasc Res 2005; 65: 411-8.
83. Ahmed S, Moschos ChB, Lyons MM, Olderwurtel HA, Coumbis RJ, Regan MJ. Cardiovascular effects of long-term cigarette smoking and nicotine administration. Am J Cardiol 1976; 37: 33-40.
84. Bellet S, DeGuzman NT, Kostis JB, Roman L, Fleischman D. Effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. Am Heart J 1972; 83: 67-76.
85. Astrup P. Carbon monoxide, smoking, and cardiovascular disease. Circulation 1973; 48: 1167-8.